文献速递脊柱关节炎

强直性脊柱炎中升高的Th17细胞与心血管并发症相关

Elevated Th17 cells are associated with cardiovascular complications in ankylosing spondylitis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本研究为回顾性研究,纳入117例强直性脊柱炎(AS)患者(46例合并心血管疾病[CVD],71例无CVD),用流式细胞术检测淋巴细胞和CD4+T细胞比例与绝对数,logistic回归分析显示升高的Th17细胞与AS患者CVD并发症相关(OR=1.20,P=0.016),ROC曲线下面积0.729(95%CI:0.632,0.825,P<0.001)。

要点

  • AS-CVD组Th17/Treg比值0.30 vs AS无CVD组0.19(P=0.014),Th17细胞绝对数7.27 cells/μL vs 4.34 cells/μL(P<0.001)。
  • 多因素logistic回归显示升高的Th17细胞与AS患者CVD并发症相关(OR=1.20,P=0.016)。
  • ROC曲线显示Th17细胞有助于区分AS合并CVD患者,AUC为0.729(95%CI:0.632,0.825,P<0.001)。

核心结论

  • 研究结果为AS中Th17细胞与心血管风险增加之间的关联提供了证据。
  • Th17细胞可能促进AS患者动脉粥样硬化加速和心血管负担增加,并可能对AS-CVD的早期评估和管理有价值。

研究设计与样本

  • 回顾性研究纳入117例AS患者,其中46例合并CVD(AS-CVD组)、71例无CVD(AS无CVD组)。
  • 采用流式细胞术检测淋巴细胞和CD4+T细胞的比例与绝对数,采用logistic回归分析CVD与临床标志物的关联。

主要发现

  • AS-CVD组Th17/Treg细胞比值0.30 vs AS无CVD组0.19(P=0.014)。
  • AS-CVD组Th17细胞绝对数7.27 cells/μL vs AS无CVD组4.34 cells/μL(P<0.001)。
  • 多因素logistic回归显示升高的Th17细胞与AS患者CVD并发症相关(OR=1.20,P=0.016)。
  • ROC曲线显示Th17细胞对区分AS合并CVD有贡献,AUC为0.729(95%CI:0.632,0.825,P<0.001)。

关键数值与推荐

  • AS-CVD组Th17/Treg比值0.30 vs AS无CVD组0.19(P=0.014)。
  • AS-CVD组Th17细胞绝对数7.27 cells/μL vs AS无CVD组4.34 cells/μL(P<0.001)。
  • 升高的Th17细胞与AS患者CVD并发症相关(OR=1.20,P=0.016)。
  • Th17细胞区分AS合并CVD的AUC为0.729(95%CI:0.632,0.825,P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with ankylosing spondylitis (AS) carry an increased burden of cardiovascular diseases (CVD), but features denoting the development of CVD in AS are unclear. This study aimed to evaluate the percentage and absolute number of lymphocytes and CD4+T cells in AS patients complicated with CVD (AS-CVD) and determine whether circulating T helper 17 (Th17) cells are associated with the development of CVD in AS. METHOD: A total of 117 AS patients (46 had CVD and 71 had no CVD) were enrolled in this retrospective study. The percentage and absolute number of lymphocytes and CD4+T cells were determined by flow cytometry. Associations between CVD and clinical markers were analysed using logistic regression. RESULTS: The ratio of Th17/Treg cells (0.30 vs 0.19, P = 0.014) and the absolute number of Th17 cells (7.27 cells/μL vs 4.34 cells/μL, P < 0.001) was significantly elevated in AS-CVD group compared with AS-no-CVD group. Multivariate logistic regression revealed that elevated Th17 cells (OR = 1.20, P = 0.016) were associated with CVD complications in AS. Receiver operating characteristic (ROC) curves showed a contribution of Th17 cell for distinguishing AS patients with CVD, with the areas under the ROC curve (AUCs) of 0.729 (95% CI: 0.632, 0.825, P < 0.001). CONCLUSION: Our findings provide evidence for the association between Th17 cells and increased cardiovascular risk in AS. Th17 cells may contribute to accelerated atherogenesis and increased cardiovascular burden in AS and be valuable for early assessment and management of AS-CVD.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Ding T, Li B, Su R, et al. Elevated Th17 cells are associated with cardiovascular complications in ankylosing spondylitis. Rheumatology (Oxford). 2022. PMID: 34894210. doi:10.1093/rheumatology/keab888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。